文献速递脑血管病

短暂与轻微神经系统症状患者的临床诊断与磁共振成像:一项前瞻性队列研究

Clinical Diagnosis and Magnetic Resonance Imaging in Patients With Transient and Minor Neurological Symptoms: A Prospective Cohort Study.
PubMed 文献 · Stroke · 2022-08-09

前瞻性队列纳入272例短暂或轻微神经系统症状患者,在发病5天内完成脑MRI。临床诊断为 probable TIA/卒中者急性缺血检出率为31%,possible者为17%,uncertain者为20%;按NINDS标准TIA/卒中者检出率42%,偏头痛先兆者11%。MRI后额外5%患者计划加用抗血小板药;18个月内MRI显示急性缺血者新发缺血性卒中风险显著高于无缺血者(年龄校正HR 13)。

要点

  • 临床诊断为possible TIA/卒中者中17%存在MRI急性缺血证据。
  • 按NINDS标准TIA/卒中者MRI急性缺血检出率为42%。
  • MRI后5%患者计划加用抗血小板药。

核心结论

  • 在初始非卒中/TIA诊断或诊断不确定的短暂或轻微神经系统症状患者中,约六分之一存在MRI急性脑缺血证据。

研究设计与样本

  • 前瞻性队列研究,纳入来自急诊和门诊的短暂或轻微神经系统症状参与者,共272例(47%女性,平均年龄60岁,SD 14),58%在发病2天内完成MRI。

主要发现

  • 临床诊断为probable TIA/卒中者MRI急性缺血为75例中23例(31% [95%CI 21%-42%]),possible者为151例中26例(17% [12%-24%]),uncertain者为43例中9例(20% [10%-36%])。
  • 按NINDS标准TIA/卒中者MRI急性缺血为95例中40例(42% [32%-53%]),偏头痛先兆者为38例中4例(11% [3%-25%]),非TIA局灶症状者为99例中16例(16% [10%-25%]),无局灶特征者为29例中1例(3% [0%-18%])。
  • MRI后与MRI前治疗计划相比,额外14例(5% [95%CI 3-8])计划接受抗血小板药物治疗。
  • 18个月内新发缺血性卒中在MRI有急性缺血证据者中为61例中9例(18%),在无证据者中为211例中2例(1%)(年龄校正HR 13 [95%CI 3-62];P<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The utility of magnetic resonance imaging (MRI) brain in patients with transient or minor neurological symptoms is uncertain. We sought to determine the proportion of participants with transient or minor neurological symptoms who had MRI evidence of acute ischemia at different clinical probabilities of transient ischemic attack (TIA) or minor stroke. METHODS: Cohort of participants with transient or minor neurological symptoms from emergency and outpatient settings. Clinicians at different levels of training gave each participant a diagnostic probability (probable when TIA/stroke was the most likely differential diagnosis; possible when TIA/stroke was not the most likely differential diagnosis; or uncertain when diagnostic probability could not be given) before 1.5 or 3T brain MRI ≤5 days from onset. Post hoc, each clinical syndrome was defined blind to MRI findings as National Institute of Neurological Disorders and Stroke criteria TIA/stroke; International Headache Society criteria migraine aura; non-TIA focal symptoms; or nonfocal symptoms. MRI evidence of acute ischemia was defined by 2 reads of MRI. Stroke was ascertained for at least 90 days and up to 18 months after recruitment. RESULTS: Two hundred seventy-two participated (47% female, mean age 60, SD 14), 58% with MRI ≤2 days of onset. Most (92%) reported focal symptoms. MR evidence of acute ischemia was found, for stroke/TIA clinical probabilities of probable 23 out of 75 (31% [95% CI, 21%-42%]); possible 26 out of 151 (17% [12%-24%]); and uncertain 9 out of 43, (20% [10%-36%]). MRI evidence of acute ischemia was found in National Institute of Neurological Disorders and Stroke criteria TIA/stroke 40 out of 95 (42% [32%-53%]); migraine aura 4 out of 38 (11% [3%-25%]); non-TIA focal symptoms 16 out of 99 (16% [10%-25%]); and no focal features 1 out of 29 (3% [0%-18%]). After MRI, a further 14 (5% [95% CI, 3-8]) would be treated with an antiplatelet drug compared with treatment plan before MRI. By 18 months, a new ischemic stroke occurred in 9 out of 61 (18%) patients with MRI evidence of acute ischemia and 2 out of 211 (1%) without (age-adjusted hazard ratio, 13 [95% CI, 3-62]; P<0.0001). CONCLUSIONS: MRI evidence of acute brain ischemia was found in about 1 in 6 transient or minor neurological symptoms patients with a nonstroke/TIA initial diagnosis or uncertain diagnosis. Methods to determine the clinical and cost-effectiveness of MRI are needed in this population.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Whiteley WN, MacRaild A, Wang Y, et al. Clinical Diagnosis and Magnetic Resonance Imaging in Patients With Transient and Minor Neurological Symptoms: A Prospective Cohort Study. Stroke. 2022. PMID: 35942881. doi:10.1161/STROKEAHA.122.039082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。